HomeNewsIndiaSingapore and India further cement bilateral relations despite challenges posed by COVID-19 pandemic

Singapore and India further cement bilateral relations despite challenges posed by COVID-19 pandemic

Though the pandemic crippled the global business environment, the city-state has been one of the largest sources of foreign investment in India in 2020-2021.

December 27, 2021 / 11:51 IST
Story continues below Advertisement
Omicron cases are on the rise in India. The variant is three times as contagious as the Delta variant.
Omicron cases are on the rise in India. The variant is three times as contagious as the Delta variant.

India and Singapore further consolidated their strategic relations in 2021 despite the challenges posed by the Covid-19 pandemic, with high-level bilateral visits and meetings leading to increased collaboration in defence, information technology and cybersecurity that are likely to shape the future of both the countries.

Though the pandemic crippled the global business environment, the city-state has been one of the largest sources of foreign investment in India in 2020-2021.

Story continues below Advertisement

India received USD 81.72 billion as Foreign Direct Investment from Singapore in 2020-21, up 10 per cent from the previous financial year.

"Our bilateral trade with Singapore has recovered from the disruptions of the past year, and is on track to touch new heights," the Acting Indian High Commissioner, Siddhartha Nath, told PTI as one of the most challenging years came to a close.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show